Table of Contents
Chapter 1. Global Branded Generics Market Executive Summary
1.1. Global Branded Generics Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Drug Type
1.3.3. By Route of Administration
1.3.4. By Indication
1.3.5. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Branded Generics Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Branded Generics Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Consumer Awareness
3.1.2. Rising Healthcare Expenditure
3.1.3. Increasing Patent Expirations
3.2. Market Challenges
3.2.1. Stringent Regulatory Requirements
3.2.2. Price Erosion Due to Competition
3.3. Market Opportunities
3.3.1. Advancements in Pharmaceutical Research
3.3.2. Development of Bioequivalent Products
Chapter 4. Global Branded Generics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Branded Generics Market Size & Forecasts by Product (2022-2032)
5.1. Segment Dashboard
5.2. Global Branded Generics Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Trade Named Generics
5.2.2. Value-Added
Chapter 6. Global Branded Generics Market Size & Forecasts by Drug Type (2022-2032)
6.1. Segment Dashboard
6.2. Global Branded Generics Market: Drug Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Alkylating Agents
6.2.2. Anti-depressants
6.2.3. Anti-epileptics
6.2.4. Anti-hypertensive
6.2.5. Anti-psychotics
6.2.6. Antimetabolites
6.2.7. Hormones
6.2.8. Lipid Lowering Drugs
Chapter 7. Global Branded Generics Market Size & Forecasts by Route of Administration (2022-2032)
7.1. Segment Dashboard
7.2. Global Branded Generics Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Oral
7.2.2. Parenteral
7.2.3. Topical
Chapter 8. Global Branded Generics Market Size & Forecasts by Indication (2022-2032)
8.1. Segment Dashboard
8.2. Global Branded Generics Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Acute & Chronic Pain
8.2.2. Cardiovascular Diseases
8.2.3. Dermatological Diseases
8.2.4. Gastrointestinal Diseases
8.2.5. Neurological Diseases
8.2.6. Oncology
Chapter 9. Global Branded Generics Market Size & Forecasts by Distribution Channel (2022-2032)
9.1. Segment Dashboard
9.2. Global Branded Generics Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
9.2.1. Offline
9.2.2. Online
Chapter 10. Global Branded Generics Market Size & Forecasts by Region (2022-2032)
10.1. North America Branded Generics Market
10.1.1. U.S. Branded Generics Market
10.1.1.1. Product breakdown size & forecasts, 2022-2032
10.1.1.2. Drug Type breakdown size & forecasts, 2022-2032
10.1.1.3. Route of Administration breakdown size & forecasts, 2022-2032
10.1.1.4. Indication breakdown size & forecasts, 2022-2032
10.1.1.5. Distribution Channel breakdown size & forecasts, 2022-2032
10.1.2. Canada Branded Generics Market
10.2. Europe Branded Generics Market
10.2.1. U.K. Branded Generics Market
10.2.2. Germany Branded Generics Market
10.2.3. France Branded Generics Market
10.2.4. Spain Branded Generics Market
10.2.5. Italy Branded Generics Market
10.2.6. Rest of Europe Branded Generics Market
10.3. Asia-Pacific Branded Generics Market
10.3.1. China Branded Generics Market
10.3.2. India Branded Generics Market
10.3.3. Japan Branded Generics Market
10.3.4. Australia Branded Generics Market
10.3.5. South Korea Branded Generics Market
10.3.6. Rest of Asia-Pacific Branded Generics Market
10.4. Latin America Branded Generics Market
10.4.1. Brazil Branded Generics Market
10.4.2. Mexico Branded Generics Market
10.4.3. Rest of Latin America Branded Generics Market
10.5. Middle East & Africa Branded Generics Market
10.5.1. Saudi Arabia Branded Generics Market
10.5.2. South Africa Branded Generics Market
10.5.3. Rest of Middle East & Africa Branded Generics Market
Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Abbott Laboratories
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Market Strategies
11.3.2. Ajanta Pharma Ltd.
11.3.3. Alkem Laboratories Ltd.
11.3.4. Amneal Pharmaceuticals LLC
11.3.5. Apotex Inc.
11.3.6. Aspen Pharmacare Holdings Limited
11.3.7. AstraZeneca PLC
11.3.8. Aurobindo Pharma Limited
11.3.9. Bausch Health Companies Inc.
11.3.10. Bristol-Myers Squibb Company
11.3.11. Cipla Limited
11.3.12. Dr. Reddy's Laboratories Ltd.
11.3.13. Endo International PLC
11.3.14. Eris Lifesciences Limited
11.3.15. Fresenius Kabi AG
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes